Cancer Supportive Care Products Market: Segment Snapshot and Table of Content (2016-2021)

Rising prevalence of cancers and adverse effects cases during cancer treatment will remain the most prominent factor driving the demand for cancer supportive care products on a global level. FMI indicates steady growth prospects for the global cancer supportive care products market over 2016-2021. The market is likely to reach US$ 25.35 Bn in 2016. Erythropoietin stimulating agents will register the highest consumption. North America is expected to retain the largest market.

Request report toc@ https://www.futuremarketinsights.com/reports/cancer-supportive-care-products-market

By drug class, the global cancer supportive care products market has eight key segments i.e. non-steroidal anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors. Erythropoietin stimulating agents segment will continue to dominate with over 24% value share in 2016. Granulocyte colony stimulating factors will however be the second largest segment with almost 20% market share by 2016 end.

Based on disease indication, lung cancer will continue to dominate other segments, including melanoma, leukemia, breast cancer, liver cancer, prostate cancer, bladder cancer, ovarian cancer, and others. Breast cancer segment is likely to emerge at the highest growth rate. This growth is attributed to increasing cases of genetic inheritance, evolving lifestyle of women, and rising adoption of hormone replacement therapy.

Request to sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2550

On the basis of distribution channel, the market is classified into three key segments viz. hospital pharmacies, retail pharmacies, and compounding pharmacies.

By geography, North America will remain the key market with over 43% market value share, followed by Europe with around 20% share by 2016, in terms of revenues. However, APAC is expected to witness at the fastest growth rate, creating the most lucrative market.

Summary of Table of Content

1. Executive Summary
2. Research Methodology
3. Assumption & Acronyms Used
4. Market Overview
5. Regulations & PEST Analysis
6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class
7. Global Cancer Supportive Care Products Market Analysis and Forecast By Indication
8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution Channel
9. Global Cancer Supportive Care Products Market Analysis and Forecast By Region
10. North America Cancer Supportive Care Products Market Analysis
11. Latin America Cancer Supportive Care Products Market Analysis
12. Latin America Cancer Supportive Care Products Market Analysis
13. Europe Cancer Supportive Care Products Market Analysis
14. Asia Pacific Cancer Supportive Care Products Market Analysis
15. MEA Cancer Supportive Care Products Market Analysis 16. Competitive Landscape

Request to Browse Full Table of Content, figure and Tables@ https://www.futuremarketinsights.com/toc/rep-gb-2550

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.